Tech Company Financing Transactions
EternoGen Funding Round
EternoGen closed a $1.1 million Series A funding round on 7/26/2013. Investors included private investors.
Transaction Overview
Company Name
Announced On
7/26/2013
Transaction Type
Venture Equity
Amount
$1,065,000
Round
Series A
Investors
Proceeds Purpose
The money from the fundraising round will go toward human studies in Europe and Asia, where EternoGen plans to launch commercially before seeking regulatory approval in the US.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1601 South Providence Rd. 119
Columbia, MO 65203
USA
Columbia, MO 65203
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
EternoGen's unique approach shields purified collagen matrices from enzymatic degradation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Silvia Codony
Chief Scientific Officer
Dale DeVore
VP - Regulatory Affairs
Rebecca Rone
Browse more venture capital transactions:
Prev: 7/26/2013: PlanG Holdings venture capital transaction
Next: 7/26/2013: Telligent venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on funding rounds that are announced publicly. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs